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REVIEW ARTICLE
Eversion vs Conventional Carotid Endarterectomy: a Systematic Review
P. Cao∗, P. De Rango and S. Zannetti
Unita` Operativa di Chirurgia Vascolare, Policlinico Monteluce, Perugia, Italy
Objective: to determine whether eversion carotid endarterectomy (CEA) was safe and more effective than conventional
CEA.
Methods: controlled trials comparing eversion vs conventional technique for CEA were identified from the Cochrane
Stroke Review Group database plus additional hand searching. Researchers were contacted to identify additional published
and unpublished studies. Randomised and pseudorandomised trials comparing eversion to conventional techniques in
patients undergoing CEA were examined. Outcomes included stroke and death, carotid restenosis/occlusion, and local
complications.
Results: five trials were included comprising 2465 patients and 2590 arteries. There were no significant differences in
the rate of perioperative stroke or death (1.7% vs 2.6%, odds ratio [OR] 0.44, 95% confidence interval [CI] 0.10–1.82)
and stroke during follow-up (1.4% vs 1.7%; OR: 0.84; 95% CI: 0.43–1.64) between eversion and conventional CEA
techniques. Eversion CEA was associated with a significantly lower rate of restenosis >50% during follow-up (2.5% vs
5.2%, OR: 0.48, 95% CI: 0.32–0.72). There were no statistically significant differences in local complications between
the eversion and conventional group. When eversion procedures were compared with patch procedures only, non-significant
differences were found in primary outcomes.
Conclusions: eversion CEA may be associated with low risk of arterial occlusion and restenosis. However, numbers are
too small to definitively assess the benefits and disadvantages of eversion CEA. Reduced restenosis rates did not appear
to be associated with clinical benefit in terms of reduced stroke risk, either perioperatively or later. Until further evidence
is available, the choice of the CEA technique should be based on the experience and familiarity of the individual surgeon.
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transverse rather than a longitudinal arteriotomy, thusIntroduction
the artery is less prone to restenosis, particularly when
sutures are placed at the widest part of the artery (i.e.In the last few decades carotid endarterectomy (CEA)
common carotid artery or the base of the carotid bulb).has undergone intensive evaluation, criticism, and
The reported perioperative major complication rate insubsequent acceptance as an effective method for
patients undergoing eversion CEA, as part of non-stroke prevention.1–5 Indications for CEA have been
randomised case series, ranges from 1 to 4%.8–19 Long-defined, outcomes have markedly improved, but the
term risk of recurrent stenosis is low (about 1% overideal surgical technique to optimise early outcome and 5 years).20 However, if not performed properly, there
long-term durability of CEA has yet to be determined. is the possibility that a distal intimal flap may remain,
Conventional CEA, performed through a longitudinal with potentially dangerous consequences.
arteriotomy of the internal carotid artery, is the most There is still much controversy regarding the be-
frequently employed technique. Eversion en- nefits of the different surgical techniques for CEA. We
darterectomy of the carotid artery was initially re- performed a systematic review to determine efficacy
ported by De Bakey et al. and later described by and safety of eversion CEA with respect to the con-
Etheredge.6,7 This technique is performed through a ventional technique for CEA (performed either with
primary closure or patch angioplasty). This is an
abbreviated version of the review published in the∗ Please address all correspondence to: P. Cao, Unita` Operativa di
Chirurgia Vascolare, Policlinico Monteluce, Perugia, 06122, Italy. Cochrane Library.21
1078–5884/02/030195+07 $35.00/0  2002 Elsevier Science Ltd. All rights reserved.
P. Cao et al.196
Table 1. Search strategy assess quality. The following items were evaluated:
method of randomisation (i.e. generation of the ran-For purposes of this review, the MEDLINE database was
systematically searched from 1966 to December 1999. The domised sequence and concealment of the random
following strategy was used: sequence from physicians participating in the trial),
1 endarterectomy, carotid/ blinding of the assessment (duplex and clinical), and
2 exp carotid arteries/ number of patients lost to follow-up. When any of the3 exp carotid artery diseases/
above details was not available from the published4 carotid.tw
5 2 or 3 or 4 report, the authors were contacted directly for further
6 endarterectomy/ or (endarterectomy or surgery).tw information.7 5 and 6
For each treatment group were counted as outcome8 exp carotid arteries/su
9 exp carotid artery diseases/su measures: (a) Any stroke or death within 30 days of
10 1 or 7 or 8 or 9 operation (perioperative); (b) Any stroke occurring11 (eversion or division endarterectomy).tw
after 30 days and perioperative deaths; (c) Carotid12 10 and 11
restenosis or occlusion, early or during follow-up; (d)
Cardiac events within 30 days of operation (peri-
Methods operative); (e) Local complications within 30 days or
later (cranial nerve injuries, ruptured artery, infection,
Search strategy pseudoaneurysm formation, etc.)
Strokes were classified as disabling or non-disabling
Trials were identified through searches of MEDLINE, (as defined by trial authors), fatal or non-fatal, contra-
the Cochrane Database of Systematic Reviews, the lateral, ipsilateral, brainstem, haemorrhage, or infarct.
Cochrane controlled clinical trial register and by sys- Outcomes were analysed on an intention-to-treat basis.
tematic hand-searching relevant journals using the Proportional risk reductions were calculated based
search strategy of the Cochrane Stroke Review Group21 on a weighted estimate of the odds ratio using the
(Table 1). Peto method.22 The statistical package, RevMan, pro-
vided by the Cochrane Collaboration was used.
Heterogeneity was tested between trials using the
standard Chi-squared test. Significance levels less thanSelection criteria
0.05 were assumed.
All randomised controlled trials (RCT), comparing
eversion with conventional CEA, employing true ran-
domisation and pseudorandomisation methods pub-
Resultslished or unpublished, were identified and analysed.
Studies were included when the surgical operation
Six trials with preliminary relevance for purposes ofperformed was conventional (longitudinal arteriotomy
this review were identified.23–28 One, published onlyclosed by patch or primary closure) or eversion (carotid
as an abstract,23 was excluded from the analysis. Over-transection and reimplantation through transverse or
all, five trials were included comprising 2465 patientsoblique suture line) CEA, follow-up was systematic,
and 2590 arteries.and patients were followed up with clinical and/
In some trials the artery was randomised rather thanor imaging techniques. However, separate subgroup
the patient, and it was therefore possible for patientsanalysis comparing eversion with only patch pro-
undergoing bilateral endarterectomies (and exposedcedures (excluding primary closure) was planned.
twice to risk) to have each artery randomised to aStudies focusing on carotid surgery performed in
different procedure. We planned to analyse clinicalcombination with some other operation (i.e. coronary
outcome (death and stroke) only in those who hadartery by-pass grafting, surgery of the epiaortic vessels
unilateral procedure or who had the same procedureetc.) were excluded.
to both arteries. As a result, in the present review, 4
trials were eligible for the main analysis of clinical
outcomes24,26–28 (2363 patients; 1190 randomised to ever-
sion CEA and 1173 to conventional CEA) and 5 trialsData collection and analysis
were eligible for the main analysis of morphological
outcome (2590 arteries).24–28Two reviewers (PDR, SZ) extracted data and assessed
trial quality independently. Discrepancies were re- Mean age of patients was 68 years (range 38–92
years) and male patients were twice as many assolved by discussion. No score system was used to
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Table 2. Characteristics of studies.
Ballotta ’99 Ballotta ’00∗ Balzer ’98 EVEREST Vanmaele ’94
Type of study Monocentric Monocentric Monocentric Multicentric Monocentric
Randomisation List of casual List of casual Blocks of 50 Computer- List of casual
numbers based on numbers based on generated list numbers based on
binary digits binary digits stratified per centre binary digits
(0 or 1) (0 or 1) (0 or 1)
Allocation Sequentially Sequentially No use of Sequentially
numbered, sealed numbered, sealed numbered numbered, sealed
envelopes envelopes envelopes envelopes
Sample size No No 300 per group 600 per group No
calculation
Quality A A B A B
concealment
Recruitment period 5 years 1 year 30 months 2 years
Mean follow-up 34 months 40 months 24 months 33 months 338 days
Patients lost None None 22 11 None
Patients recruited 310 68 564 1353 170
% Asymptomatic 46 36 56 23
% Female 31 25 34 27 23
Mean age 70 70 66 69 65
CEA recruited 336 68 bilateral 564 1353 200
Interventions 169 eversion & 167 68 eversion &68 286 eversion & 278 678 eversion & 675 102 eversion & 98
PTFE patch PTFE patch dacron patch conventional (419 saphenous vein
primary closure + patch
256 patch)
∗ Eighteen patients previously enrolled in the other RCT study by the same author were excluded.
A=adequate; B=not clear.
females. All trials included patients with symptomatic The overall risk of any perioperative stroke (fatal,
non-fatal, contralateral, ipsilateral brainstem, haem-and asymptomatic carotid disease. There was no im-
balance in the rates of risk factors between the eversion orrhage, or infarct) was 1.7% (41/2363) with no sig-
nificant differences in the eversion group [17/1190and conventional groups in all studies examined. Fol-
low-up ranged from 1 to 69 months. Overall, 33 (1.42%)] and in the conventional group [24/1173 (2%);
OR random effect model 0.49; 95% CI 0.12–1.96, p=n.s.patients were lost to follow-up: 20 in the eversion
group and 13 in the conventional group. Details of the (not significant)]. Similarly, there were no significant
differences in the rates of perioperative disabling orincluded studies are shown in Table 2.
All trials included in the review had two arms of ipsilateral strokes between eversion and conventional
CEA.randomisation: eversion and conventional CEA tech-
niques. In the EVEREST trial, the eversion technique Rates of early carotid occlusion within 30 days of
surgery were not significantly lower in eversion groupwas compared to both primary closure and patch
angioplasty techniques for conventional carotid en- with respect to conventional group: 0.68% occlusions
in eversion CEAs and 1.1% in conventional CEAs (ORdarterectomy.28,29 In the other studies, only patch an-
gioplasty using saphenous vein25 or dacron24 or random effect model 0.70, 95% CI 0.24–1.58; p=n.s.).
No significant differences were found in the rates ofpolytetrafluoroethylene26,27 was considered for com-
parison with the eversion technique. perioperative myocardial infarction neither in the rates
of local complications (neck haematoma and cranialA subgroup analysis was performed to compare
outcome of patch vs eversion CEA. nerve injuries).
Compared with conventional CEA, carotid re-There were no clear differences in clinical outcomes
between eversion and conventional CEA. Peri- stenosis rates >50% during follow-up were sig-
nificantly lower in the eversion CEA, but stroke ratesoperative death and stroke rates did not differ sig-
nificantly. Overall risk of any stroke or death within did not differ (2% vs 2.4%; OR random effect model
0.75, 95% CI 0.30–1.93; p=n.s.) (see Figs 2 and 3). All30 days of surgery is shown in Fig. 1 and was 2.1%
(51/2363): 1.7% events occurred in the eversion CEA studies had a minimum follow-up of 1 year. Thirty-
three arteries were lost to follow-up, 20 in the eversiongroup and 2.6% in the conventional CEA group for
an Absolute Risk Reduction of 0.96 and a Relative CEA group and 13 in the conventional CEA group. If
all arteries lost to follow-up were assumed not to haveRisk Reduction of 37% (OR random effect model 0.44,
95% CI 0.10–1.82; p=NS). been restenosed or occluded (best clinical scenario),
Eur J Vasc Endovasc Surg Vol 23, March 2002
P. Cao et al.198
Outcome: perioperative stroke or death
Study
01 class A studies (randomized)
Ballotta 1999 0 / 158 7 / 152
Ballotta 2000 0 / 68 0 / 68
EVEREST 1998 17 / 678 15 / 675
Subtotal(95%CI) 17 / 904 22 / 895
Test for heterogeneity  chi-square=4.16  df=1  p=0.041
Test for overall effect  z=0.68  p=0.5
02 Class B studies (pseudorandomized)
Balzer 1998 3 / 286 9 / 278
Subtotal(95%CI) 3 / 286 9 / 278
Test for heterogeneity chi-square=0.0 df=0
Test for overall effect  z=1.71  p=0.09
Total(95%CI) 20 / 1190 31 / 1173
Test for heterogeneity chi-square=6.21 df=2 p=0.045
Test for overall effect  z=1.14  p=0.3
16.8 0.06[0.00,1.08]
0.0 Not Estimable
46.8 1.13[0.56,2.28]
63.6 0.36[0.02,6.84]
36.4 0.32[0.08,1.18]
36.4 0.32[0.08,1.18]
100.0 0.44[0.10,1.82]
eversion
n/N
conventional
n/N
OR
(95%CI Random)
Weight
%
OR
(95%CI Random)
eversion better eversion worse
Fig. 1. Effect of eversion vs conventional CEA on perioperative stroke or death. Odds Ratios (OR) with random effect model and 95%
Confidence Intervals (CI) are displayed. The black squares represent the point estimates (effect size) for the randomised trials. The bars
on either side of the squares are 95% CI. Arrows mean that the differences were not statistically significant but the 95% CI could not be
determined. The vertical line indicating an effect size of 0 is the line at which eversion CEA was found to have no effect. OR to the left
of that line (lower than 0) indicate that outcome was better with eversion CEA; those to the right (higher than 0) indicate that outcome
was worse with eversion CEA. When the 95% CI does not span the “no difference” line at 0, the study findings are considered to be
significant (p=0.05).
Outcome: restenosis
Study
01 class A studies (randomized)
Ballotta 1999 0 / 169 8 / 161
Ballotta 2000 1 / 68 9 / 68
EVEREST 1998 19 / 671 37 / 673
Vanmaele 1994 1 / 97 2 / 90
Subtotal(95%CI) 21 / 1005 56 / 992
Test for heterogeneity  chi-square=4.50  df=3  p=0.021
Test for overall effect  z=2.35  p=0.02
02 Class B studies (pseudorandomized)
Balzer 1998 11 / 285 10 / 275
Subtotal(95%CI) 11 / 285 10 / 275
Test for heterogeneity  chi-square=0.0  df=0
Test for overall effect  z=0.14  p=0.9
Total(95%CI) 32 / 1290 66 / 1267
Test for heterogeneity  chi-square=7.80  df=4  p=0.099
Test for overall effect  z=1.92  p=0.05
7.3 0.05[0.00,0.93]
12.0 0.10[0.01,0.80]
39.6 0.50[0.29,0.88]
9.6 0.46[0.04,5.14]
68.4 0.29[0.10,0.81]
31.6 1.06[0.44,2.55]
31.6 1.06[0.44,2.55]
100.0 0.44[0.19,1.02]
eversion
n/N
conventional
n/N
OR
(95%CI Random)
Weight
%
OR
(95%CI Random)
eversion better eversion worse
Fig. 2. Effect of eversion vs conventional CEA on restenosis with the best clinical scenario (i.e. assuming that all arteries lost to follow-
up are patent). Odds Ratios (OR) with random effect model and 95% Confidence Intervals (CI) are displayed. The black squares represent
the point estimates (effect size) for the randomised trials. The bars on either side of the squares are 95% CI. Arrows mean that the
differences were not statistically significant but the 95% CI could not be determined. The vertical line indicating an effect size of 0 is the
line at which eversion CEA was found to have no effect. OR to the left of that line (lower than 0) indicate that outcome was better with
eversion CEA; those to the right (higher than 0) indicate that outcome was worse with eversion CEA. When the 95% CI does not span
the “no difference” line at 0, the study findings are considered to be significant (p=0.05).
eversion CEA was associated with a risk of carotid model 0.44, 95% CI 0.19–1.02). The number of patients
needed to undergo treatment to prevent one restenosisrestenosis of 2.5% (32/1290) vs 5.2% ( 66/1267) for
conventional CEA (ARR 2.7; RRR 52%; OR fixed effect [Number Needed to Treat (NNT)] was 37. Yet, if all
the arteries lost to follow-up in the eversion group0.48, 95% CI 0.32–0.72; p=0.0007; OR random effect
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Outcome: any stroke after 30 days and perioperative death
Study
Ballotta 1999 0 / 169 4 / 152
Balzer 1998 2 / 286 3 / 278
EVEREST 1998 21 / 678 20 / 675
Total(95%CI) 23 / 1133 27 / 1105
Test for heterogeneity  chi-square=2.65  df=2  p=0.27
Test for overall effect  z=0.58  p=0.6
9.2 0.10[0.01,1.82]
21.2 0.65[0.11,3.89]
69.6 1.05[0.56,1.95]
100.0 0.76[0.30,1.93]
eversion
n/N
conventional
n/N
OR
(95%CI Random)
Weight
%
OR
(95%CI Random)
eversion better eversion worse
Fig. 3. Effect of eversion vs conventional CEA on any stroke after 30 days and perioperative death. Odds Ratios (OR) with random effect
model and 95% Confidence Intervals (CI) are displayed. The black squares represent the point estimates (effect size) for the randomised
trials. The bars on either side of the squares are 95% CI. Arrows mean that the differences were not statistically significant but the 95%
CI could not be determined. The vertical line indicating an effect size of 0 is the line at which eversion CEA was found to have no effect.
OR to the left of that line (lower than 0) indicate that outcome was better with eversion CEA; those to the right (higher than 0) indicate
that outcome was worse with eversion CEA. When the 95% CI does not span the “no difference” line at 0, the study findings are
considered to be significant (p=0.05).
were assumed to have become restenosed while none events (i.e. perioperative or late stroke) when com-
of those lost to follow-up in the conventional group pared to conventional CEA.
became restenosed (worst clinical scenario), the results The absolute risk of stroke and/or death within 30
are not significant (OR 0.78, 95% CI 0.54–1.13, p=n.s.). days of CEA found in our review was exceptionally
Perioperative carotid occlusions were excluded from low regardless of the type of treatment: 51/2363 (2.1%).
the analysis of restenosis. This finding could be due to the high proportion
Sensitivity analyses were performed to test whether (balanced between treatment groups) of asymptomatic
the treatment effect still remained when the poor patients in these studies.The risk of perioperative
quality trials were excluded. After sensitivity analysis stroke was particularly low in the eversion group of
the treatment effect did not vary significantly. small trials: 2/512 (0.4%) vs 11/498 (2.2%) in the
conventional CEA group. Due to the low absolute risk
of stroke, and as not all studies in this review wereSubgroup analysis: eversion vs patch
performed with rigorous methodological criteria, ourWhen eversion CEA procedures were compared with
results should be applied with caution to the generalpatch procedures only, there were non-significant dif-
population.ferences in primary outcomes. In particular, peri-
Some surgeons are reluctant to perform eversionoperative stroke or death was 1.7% for eversion CEA
CEA because there is the possibility that a distalvs 2.4% for patch CEA (ARR 0.7; OR random effect
intimal flap may remain, with potentially dangerousmodel 0.5; CI 0.06–4.01; p=n.s.); any stroke after 30
consequences. The similar and low rates for earlydays and perioperative death rates were 2% for ever-
carotid occlusion and neurological events that wesion CEA and 1.9% for patch CEA (ARR 0.1; OR
found in our review in both, eversion or conventionalrandom effect model 0.75; CI 0.23–2.47; p=n.s.); re-
CEA, do not support the hypothesis of a potentiallystenosis rates were 2.5 for eversion CEA vs 3.9 for
unsafe distal end of the carotid plaque after eversionpatch CEA (ARR 1.4; OR random effect model 0.52;
CEA. Moreover, Green et al.,30 in a recent retrospectiveCI 0.16–1.69; p=n.s.).
analysis of restenosis rates in 274 patients undergoing
eversion or patch CEA after 1 year of follow-up, found
that distal recurrences do not seem to be a problem
after eversion CEA. The authors found that incidenceDiscussion
of recurrent stenosis >50% was similar and about
4.6% for eversion and patch CEA, but the pattern ofChanges in surgical techniques may affect the outcome
restenosis differed with each technique: eversion CEAof CEA. Although encouraging results regarding re-
was more prone to develop proximal recurrent sten-stenosis rates have been described with eversion CEA,
oses while distal recurrent stenoses were more com-a relative reluctance to perform this technique remains.
mon after patch closure.The results of the present review of five randomised
In our review a statistically significant decrease intrials suggest that eversion CEA appears to be as-
sociated with a similar rate of major clinical outcome the risk of restenosis and arterial occlusion during
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follow-up in patients undergoing eversion CEA when of this trial may have biased our findings.24 Yet, con-
sidering that a small number of randomised trials werecompared to conventional CEA was observed (2.5%
eligible for this review, we felt that inclusion of a studyvs 5.2%). This was equivalent to the prevention of
in which clinical information was clearly detailedabout 100 carotid occlusion/restenosis per 3700 op-
would have enriched the meta-analysis. Some trialserated arteries with the eversion technique. In other
were too small to achieve an adequate statistical power.words, this means that eversion CEA reduces the risk
Moreover, in the smallest trials the sample size hadof restenosis by only 3%. As yet these results are not
not been calculated.26,27statistically powerful because of the limited number
In summary, there is insufficient evidence from ran-of events and the losses to follow-up. Yet, if we consider
domised trials to reliably determine the relative risksthe worst case scenario, i.e. assuming that all eversion
and benefits of eversion vs conventional CEA. It isCEA procedures lost to follow-up were occluded or
possible that carotid eversion is associated with a lowerrestenosed while none were lost in the primary closure
risk of long-term carotid occlusion and restenosis butgroup, the difference between eversion and con-
it is still not clear whether this is associated with aventional CEA became not significant.
lower rate of subsequent neurological events. Pro-There is evidence that carotid patching is associated
cedural costs were not studied in RCTs, thereby nowith reduced risk of arterial occlusion and restenosis.31
clear indication can be given on this matter. UntilHowever, the costs of prosthetic material and pro-
additional data are available, the choice of the surgicalcedural timing for patching were not determined in
technique for CEA should depend on the experiencethe analysed trials. In four studies of our review, only
and preference of the operating surgeon.CEA with patch (of different materials) was considered
in comparison to the conventional CEA group: dacron
in the study by Balzer et al.,24 polytetrafluorethylene
in the studies by Ballotta et al.,26,27 and saphenous
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